| 11534-180-19 |
11534-180 |
HUMAN OTC DRUG |
POLYETHYLENE GLYCOL 3350 NF |
polyethylene glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20170613 |
N/A |
ANDA |
ANDA206105 |
SUNRISE PHARMACEUTICAL, INC |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
119 g in 1 BOTTLE (11534-180-19) |
| 11534-180-28 |
11534-180 |
HUMAN OTC DRUG |
POLYETHYLENE GLYCOL 3350 NF |
polyethylene glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20170613 |
N/A |
ANDA |
ANDA206105 |
SUNRISE PHARMACEUTICAL, INC |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
238 g in 1 BOTTLE (11534-180-28) |
| 11534-180-50 |
11534-180 |
HUMAN OTC DRUG |
POLYETHYLENE GLYCOL 3350 NF |
polyethylene glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20170613 |
N/A |
ANDA |
ANDA206105 |
SUNRISE PHARMACEUTICAL, INC |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
510 g in 1 BOTTLE (11534-180-50) |